Clinical trial
Combination Chemotherapy in Treating Women With Stage I Breast Cancer
NCT00055679 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00055679 |
|---|---|
| Title | Combination Chemotherapy in Treating Women With Stage I Breast Cancer |
| Official title | Phase III Randomized Study Of Adjuvant Fluourouracil, Epirubicin And Cyclophosphamide, In Women With Stage I Breast Cancer |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | cyclophosphamide, epirubicin hydrochloride, fluorouracil |
| Enrollment | 1,512 |
| Start date | Aug 1, 2002 |
| Primary completion | Jun 1, 2012 |
| Completion | Jun 1, 2013 |
| First posted | Mar 7, 2003 |
| Last update posted | Jun 18, 2013 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: